Med hensyn til progressionsfri overlevelse blev der set yderst statistisk signifikante resultater for højdosis paclitaxel- armen sammenlignet med etoposid/ cisplatin (p=0. 007).
With respect to progression free survival, highly statistically significant results were noted for the high-dose paclitaxel arm compared to etoposide/ cisplatin (p= 0.007).